title: Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens.
abstract: Formation of a correctly organised vasculature and subsequently embryonic survival is critically dependent on the dosage and site-specific expression of VEGF. Murine VEGF exists in three common isoforms (viz. 120, 164 and 188 amino acids) having different organ specific distribution levels. Gene knock-in studies show that expression of any of the individual isoforms of VEGF extends survival until birth, although each is associated with distinct organ-specific abnormalities. Comparison of the effects of VEGF isoform expression is complicated by the general lethality of mis-expression, in addition to cumulative effects of adjacent tissues from the inappropriately patterned vasculature. Here we investigate the effects of over-expression of individual VEGFA isoforms from the lens-specific alphaA-Crystallin promoter and characterise their effects on the vessel morphology of the hyaloid and developing retinal vasculature. Since the hyaloid vasculature is an anatomically distinct, transient vasculature of the eye, comprising 3 cell types (endothelium, pericytes and macrophages) it is possible to more readily interpret the role of individual VEGF-A isoforms in vascular pattern formation in this model. The severity of the vascular phenotype, characterised by a hyperplastic hyaloid at E13.5 and subsequently retinal vascular patterning and ocular defects, is most severe in transgenics over-expressing the more diffusible forms of VEGFA (120 and 164), whereas in VEGFA(188) transgenics the hyaloid vascular defects partially resolve post-natally. The results of this study indicate that individual isoforms of VEGFA induce distinct vascular phenotypes in the eye during embryonic development and that their relative doses provide instructive cues for vascular patterning.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Nottingham, City Hospital, Hucknall Rd, Nottingham, NG5 1PB, UK.
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Mitchell
authors.forename: Catrin S
authors.initials: CS
authors.lastname: Rutland
authors.forename: Michael
authors.initials: M
authors.lastname: Walker
authors.forename: Muneeb
authors.initials: M
authors.lastname: Nasir
authors.forename: Alexander J E
authors.initials: AJ
authors.lastname: Foss
authors.forename: Christine
authors.initials: C
authors.lastname: Stewart
authors.forename: Holger
authors.initials: H
authors.lastname: Gerhardt
authors.forename: Moritz A
authors.initials: MA
authors.lastname: Konerding
authors.forename: Werner
authors.initials: W
authors.lastname: Risau
authors.forename: Hannes C A
authors.initials: HC
authors.lastname: Drexler
mesh_terms: D000818:Animals; D007908:Lens, Crystalline / Q000002:abnormalities / Q000098:blood supply* / Q000196:embryology*; D051379:Mice; D008822:Mice, Transgenic; D010641:Phenotype; D020033:Protein Isoforms / Q000096:biosynthesis / Q000235:genetics; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis* / Q000235:genetics*
chemical_list: D020033:Protein Isoforms; D042461:Vascular Endothelial Growth Factor A; C467480:vascular endothelial growth factor A, mouse